Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program
Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, ...
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Studying structure of G protein-coupled receptor kinases could improve an array of drugs
Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profileof VYVGART and VYVGART HytrulogMG patients on VYVGART ...
Heat-activated receptor could unlock new pain therapies
Touch a hot plate and your hand flies back. While the response is almost instant, researchers are still working to better ...
Medscape6d
Hypothyroidism and Hypertension
Water and sodium retention during severe hypothyroidism create a state of volume depletion, low extracellular fluid osmolality and increased water retention. The hypothyroid population is ...
C&EN5d
Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors
Department of Nuclear Medicine, Xinqiao Hospital, Army Medical University, Chongqing 400037, China School of Medical Imaging, North Sichuan Medical College, NanChong 637100, China Department of ...